ProMIS Neurosciences (PMN) Stock Chart & Stock Price History $1.08 -0.07 (-6.09%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ProMIS Neurosciences Stock Price Performance5 Day Performance-14.96%1 Month Performance-0.92%3 Month Performance-10.00%6 Month Performance-44.90%Year-To-Date Performance-6.09%1 Year Performance-39.33% Receive PMN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> PMN Stock Chart for Tuesday, November, 5, 2024 PMN Chart by TradingView ProMIS Neurosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$1.15$1.08-6.09%$1.17$1.0832,462 shs$32.28 million11/01/2024$1.27$1.15-9.45%$1.34$1.12107,614 shs$34.37 million10/31/2024$1.09$1.27+16.51%$1.57$1.00847,610 shs$24.08 million10/30/2024$1.03$1.09+5.83%$1.24$1.00299,568 shs$20.67 million10/29/2024$1.06$1.03-2.83%$1.08$1.0312,309 shs$19.53 million10/28/2024$1.02$1.06+3.73%$1.07$0.9719,267 shs$20.10 million Get the Latest News and Ratings for PMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$0.96$1.02+7.01%$1.06$0.9625,439 shs$19.38 million10/24/2024$0.95$0.96+0.63%$1.00$0.9351,948 shs$18.11 million10/23/2024$0.98$0.95-3.16%$1.00$0.9429,062 shs$17.99 million10/22/2024$0.95$0.98+3.16%$1.00$0.9440,655 shs$18.58 million10/21/2024$0.99$0.95-4.05%$1.02$0.9280,252 shs$18.01 million10/18/2024$1.05$0.99-5.25%$1.04$0.9927,729 shs$18.77 million10/17/2024$1.04$1.05+0.48%$1.07$1.009,169 shs$19.81 million10/16/2024$1.04$1.04$1.06$1.0013,159 shs$19.72 million10/15/2024$1.00$1.04+4.00%$1.06$0.9839,830 shs$19.72 million10/14/2024$1.02$1.00-1.96%$1.06$0.9624,101 shs$18.96 million10/11/2024$1.01$1.02+0.99%$1.07$0.9663,886 shs$30.49 million10/10/2024$1.03$1.01-1.94%$1.05$1.0036,138 shs$19.15 million10/09/2024$1.03$1.03$1.10$1.0041,695 shs$19.53 million10/08/2024$1.10$1.03-6.29%$1.11$1.0231,307 shs$19.53 million10/07/2024$1.09$1.10+0.83%$1.14$1.0335,714 shs$20.84 million10/04/2024$1.11$1.09-1.80%$1.17$1.0951,510 shs$20.67 million10/03/2024$1.23$1.11-9.76%$1.22$1.1131,395 shs$21.05 million10/02/2024$1.23$1.23$1.34$1.15130,301 shs$23.32 million10/01/2024$1.25$1.23-1.60%$1.30$1.22194,736 shs$23.32 million09/30/2024$1.28$1.25-2.34%$1.36$1.2337,770 shs$23.70 million09/27/2024$1.29$1.28-0.78%$1.43$1.2849,832 shs$24.27 million09/26/2024$1.31$1.29-1.53%$1.44$1.2943,105 shs$24.46 million09/25/2024$1.30$1.31+0.77%$1.45$1.30166,259 shs$39.16 million09/24/2024$1.23$1.30+5.69%$1.32$1.22106,909 shs$24.65 million09/23/2024$1.23$1.23$1.35$1.23150,293 shs$23.32 million09/20/2024$1.23$1.23$1.32$1.21104,641 shs$23.32 million09/19/2024$1.24$1.23-0.81%$1.38$1.2248,810 shs$23.32 million09/18/2024$1.31$1.24-5.34%$1.41$1.2329,946 shs$23.51 million09/17/2024$1.38$1.31-5.07%$1.42$1.2649,366 shs$24.84 million09/16/2024$1.23$1.38+12.20%$1.42$1.09131,477 shs$26.17 million09/13/2024$1.25$1.22-2.40%$1.30$1.1938,175 shs$36.47 million09/12/2024$1.23$1.25+1.63%$1.30$1.2125,769 shs$23.70 million09/11/2024$1.22$1.23+0.82%$1.25$1.1488,316 shs$36.77 million09/10/2024$1.25$1.22-2.40%$1.29$1.1291,394 shs$36.47 millionUnveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>>09/09/2024$1.30$1.25-3.85%$1.39$1.19104,221 shs$37.36 million09/06/2024$1.37$1.30-5.02%$1.40$1.3016,786 shs$24.65 million09/05/2024$1.32$1.37+3.70%$1.39$1.3023,901 shs$25.95 million09/04/2024$1.31$1.32+0.76%$1.33$1.267,483 shs$25.03 million09/03/2024$1.37$1.31-4.11%$1.38$1.305,326 shs$24.84 million09/02/2024$1.37$1.37$1.39$1.2619,800 shs$25.91 million08/30/2024$1.30$1.37+5.09%$1.39$1.2619,825 shs$25.91 million08/29/2024$1.34$1.30-2.99%$1.38$1.3016,583 shs$24.65 million08/28/2024$1.31$1.34+2.29%$1.39$1.2860,336 shs$25.41 million08/27/2024$1.26$1.31+3.97%$1.44$1.27229,683 shs$24.84 million08/26/2024$1.30$1.26-3.08%$1.34$1.2536,115 shs$23.89 million08/23/2024$1.25$1.30+4.00%$1.36$1.2556,249 shs$24.65 million08/22/2024$1.23$1.25+1.63%$1.29$1.1540,158 shs$23.70 million08/21/2024$1.21$1.23+1.65%$1.32$1.1925,540 shs$23.32 million08/20/2024$1.29$1.21-6.20%$1.31$1.2126,107 shs$22.94 million08/19/2024$1.25$1.29+3.20%$1.35$1.2613,203 shs$24.46 million08/16/2024$1.23$1.25+2.04%$1.30$1.2330,597 shs$23.70 million08/15/2024$1.21$1.23+1.10%$1.27$1.239,104 shs$23.23 million08/14/2024$1.20$1.21+0.98%$1.30$1.1932,338 shs$22.98 million08/13/2024$1.22$1.20-1.64%$1.29$1.1946,864 shs$22.75 million08/12/2024$1.22$1.22$1.30$1.2214,498 shs$23.13 million08/09/2024$1.23$1.22-0.81%$1.30$1.2022,051 shs$23.13 million08/08/2024$1.39$1.23-11.51%$1.32$1.2326,941 shs$23.32 million08/07/2024$1.42$1.39-2.11%$1.49$1.3742,919 shs$26.36 million08/06/2024$1.20$1.42+18.33%$1.43$1.1386,033 shs$26.93 million08/05/2024$1.33$1.20-9.77%$1.28$1.1969,162 shs$22.75 million Related Companies CytomX Therapeutics Stock Price Chart JATT Acquisition Stock Price Chart Milestone Pharmaceuticals Stock Price Chart Metagenomi Stock Price Chart Adlai Nortye Stock Price Chart Cellectar Biosciences Stock Price Chart ALX Oncology Stock Price Chart Verrica Pharmaceuticals Stock Price Chart Spero Therapeutics Stock Price Chart Citius Pharmaceuticals Stock Price Chart Receive PMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PMN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
